The Board has determined that the Veteran's multiple myeloma may be related to his service exposure to ionizing radiation and/or asbestos. The case is being remanded for a VA examination to determine the nature and etiology of the condition.
The deciding factor: The claim was reopened on new evidence, but further evaluation is needed to determine if the multiple myeloma is related to service exposure to ionizing radiation or asbestos.
- Claimed conditions
- Multiple Myeloma
- How they argued it
- Not specified
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- June 12, 2018
- Citation
- 18109845
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 18109845.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Veteran's multiple myeloma is rated as noncompensable, and the Board has determined that the disability picture does not adequately contemplate his symptoms of fatigue. The VA examiner noted marked interference with employment due to fatigue. Therefore, the claim for an increased rating is remanded for consideration of extraschedular considerations.
- Whole decision: Granted
The Veteran's death was caused by multiple myeloma, which is presumed to be related to his exposure to herbicide agents in Thailand during the Vietnam War. The Board granted service connection for the cause of the Veteran's death based on this presumption.
- Whole decision: Remanded (sent back)
The Veteran's claim for TDIU prior to December 2023 is remanded due to the presence of a 100% disability rating for multiple myeloma starting from December 21, 2023. The Board finds that the Veteran has not met the schedular criteria for a schedular TDIU rating and refers the case for extraschedular consideration.
- Whole decision: Remanded (sent back)
The Board has remanded the claims for service connection for fatigue, dizziness, and chronic kidney disease secondary to the Veteran's service-connected multiple myeloma due to a pre-decisional duty-to-assist error.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.